Literature DB >> 24812458

An introduction of Tertiary Peritonitis.

Shashi Prakash Mishra1, Satyendra Kumar Tiwary1, Manjaree Mishra2, Sanjeev Kumar Gupta1.   

Abstract

Intraperitoneal infection known as peritonitis is a major killer in the practice of clinical surgery. Tertiary peritonitis (TP) may be defined as intra-abdominal infection that persists or recurs ³48 h following successful and adequate surgical source control. A planned or on-demand relaparotomy after an initial operation is probably most frequent way to diagnose TP, but is a late event to occur. Hence it is desirable to have timely and nonoperative diagnosis of TP after the initial operation and subsequent initiation of an appropriate therapy to reduce the complications and to improve the outcome.

Entities:  

Keywords:  Mannheim peritonitis index; simplified acute physiology score II; tertiary peritonitis

Year:  2014        PMID: 24812458      PMCID: PMC4013728          DOI: 10.4103/0974-2700.130883

Source DB:  PubMed          Journal:  J Emerg Trauma Shock        ISSN: 0974-2700


INTRODUCTION

Intraperitoneal infection known as peritonitis is a major killer in the practice of clinical surgery and it is also one of the most frequent diagnoses in a surgical intensive care unit (ICU) leading to severe sepsis.[1] It can be classified as — primary, secondary, and tertiary peritonitis (TP). Primary peritonitis lacks an identifiable anatomical derangement. It is also known as spontaneous bacterial peritonitis and has a low incidence on surgical ICUs as it is managed purely without any surgical intervention and mostly by physician or intensivist. Secondary peritonitis is the most common entity in critical surgical patients and is defined as an infection of the peritoneal cavity resulting from hollow viscus perforation, anastomotic leak, ischemic necrosis, or other injuries of the gastrointestinal tract.[2] An exploratory laparotomy may be warranted to achieve surgical control of the source of infectious focus and reduction of the bacterial load. TP may be defined as a severe recurrent or persistent intra-abdominal infection after apparently successful and adequate surgical source control of secondary peritonitis.[2] Though it is less common entity but comprises of a prolonged systemic inflammation leading to a high chance of systemic inflammatory response syndrome, sepsis, severe sepsis, or septic shock; and therefore mortality in TP ranges between 30 and 64%.[12345] There is significant difference between the microbial flora in tertiary and secondary peritonitis and TP comprises of mostly opportunistic and nosocomial facultative pathogenic bacteria and fungi (e.g., Enterococci, Enterobacter, and Candida). The development of multidrug resistance has also been observed in microbes causing TP due to use of broad spectrum antibiotic therapy.

DEFINITION OF TERTIARY PERITONITIS

The standard treatment for secondary peritonitis is an urgent exploratory laparotomy with surgical source control and proper antibiotic therapy. However, a few patients develop persistent intra-abdominal infection, an altered microbial flora, failure of the immune response, and progressive organ dysfunction leading to high mortality; which may be referred to as TP. The debate continues about the definition of TP and some workers deny the existence of TP as a distinct entity. Various definitions have emphasized on failed surgical source control or inadequate antibiotic therapy of secondary peritonitis or even impaired host response to peritoneal infection.[6] This heterogeneity of definitions invited clinicians and intensivists to work out the exact parameters to label a clinical situation as TP. The latest ICU consensus conference guideline provides a precise definition of TP as intra-abdominal infection that persists or recur ≥48 h following successful and adequate surgical source control.[2] This definition contains two essential conditions, which have to be met: The time period (≥48 h) and successful surgical source control. However, there is a consensus that secondary peritonitis and TP exist in a continuum and the transition between both may be quite subtle. Although TP may be diagnosed during relaparotomy as a simple discrete point in the illness, in reality, it evolves gradually over several hours or days.

RISK FACTORS AND MICROBIAL FLORA OF TERTIARY PERITONITIS

Age of the patient, underlying etiology of peritonitis, malnutrition, and presence of multidrug resistant microorganisms has been some of the important epidemiologic and clinical risk factors which may predispose towards TP. Many workers have shown that there is a microbial shift in TP towards Enterococcus, Enterobacter, Pseudomonas, Candida albicans, and other opportunistic bacteria and fungi.[789]

DIAGNOSIS OF TP

The differentiation between secondary and TP becomes really difficult as there is usually a continuum between the two and the exact time point when secondary peritonitis turns into TP is often missed. In the cases when secondary peritonitis is diagnosed during the initial operation, a successful attempt of surgical source control (e.g., exteriorization of perforated viscus) is often enough to save prolong morbidity and mortality in the majority of patients. However, a reoperation may be indicated in a subset of patients who show clinical signs of recurrent or persistent intra-abdominal infection in spite of apparently successful source control, which is referred to as TP. It is important to differentiate the entity with an ongoing secondary peritonitis developing because of failure of the surgical attempt of the source control (e.g., failure of the surgical procedure or missed pathology), whereas in TP there is no obvious anatomical defect or perforation of the hollow viscus. A planned or on-demand relaparotomy after an initial operation is probably most frequent way to diagnose TP, but is a late event to occur.[1011] Hence, it is desirable to have timely and nonoperative diagnosis of TP after the initial operation and subsequent initiation of an appropriate therapy to reduce the complications and to improve the outcome. It is also essential to identify patients at risk for developing TP as early as possible after initial operation for secondary peritonitis.

PREDICTIVE PARAMETERS AND DIAGNOSTIC CHALLENGE

There has been no consensus till date regarding value of clinical and laboratory parameters and scoring systems for sufficient diagnosis and monitoring of TP.[5] The ICU consensus conference suggested three categories for the diagnostic certainty of TP, that is, microbiologically confirmed, probable, and possible.[2] Mannheim Peritonitis Index, Simplified Acute Physiology Score II (SAPS II), and C-reactive protein are three early and easily accessible parameters which may be utilized for identification of patients who might further develop TP. Though the objections may arise over the limited role of clinical (Mannheim Peritonitis Index, SPAS II) and laboratory parameters (C-reactive protein) for sufficient diagnosis of TP due to persisting systemic inflammation repeated surgical procedures or intermittent nosocomial infections.[5] In fact, there are conflicting data concerning the value applying such parameters for the detection of TP.[912] The Mannheim Peritonitis Index (MPI) developed and first described in 1987 by Linder et al.[13] and validated in several studies for secondary peritonitis.[1415] represents a scoring system that estimates the severity and prognosis of secondary peritonitis [Table 1]. Recent studies reported encouraging results for the Mannheim Peritonitis Index regarding detection patients at risk for TP.[78] It has to be kept in mind that the Mannheim Peritonitis Index is an early (if not the earliest) marker for TP. Its accessibility immediately during the index operation renders the Mannheim Peritonitis Index to a diagnostic tool of high potential to diagnose TP.
Table 1

The Mannheim Peritonitis Index

The Mannheim Peritonitis Index SAPS II score[8] initially designed to predict mortality and disease severity of critically ill patients on surgical ICUs has shown a potential to be successfully applied in TP.[1617] C-reactive protein constitutes a routine parameter in patients with abdominal infections.[512] The main problem of C-reactive protein is the lack of specificity for abdominal infections, and a rise of C-reactive protein during the postoperative period may simply be the result of the operative trauma.[1819202122] C-reactive protein or procalcitonin have also rarely been evaluated in the diagnosis of TP.[512] There is still a lack of studies addressing the identification of risk factors for patients prone to develop TP. Hence it still remains to have diagnostic markers that could predict the likelihood of a patient to develop TP even at the onset of peritonitis, during the initial operation, or during the first postoperative days.

CONCLUSION

Due to high mortality of TP and often delayed diagnosis, it is crucial to identify patients at risk for developing TP as early as possible, preferably at the initial operation or during the first postoperative days. The Mannheim Peritonitis Index assessed at the initial operation and the time course of C-reactive protein and SAPS II during the first days after initial operation are promising diagnostic candidates for the future.
  22 in total

1.  Surgical management of severe secondary peritonitis.

Authors:  T Koperna
Journal:  Br J Surg       Date:  2000-03       Impact factor: 6.939

2.  SIRS, MODS and tertiary peritonitis.

Authors:  P H Reemst; H van Goor; R J Goris
Journal:  Eur J Surg Suppl       Date:  1996

3.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

4.  Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group.

Authors:  A Billing; D Fröhlich; F W Schildberg
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

5.  Infectiological diagnostic problems in tertiary peritonitis.

Authors:  G Weiss; F Meyer; H Lippert
Journal:  Langenbecks Arch Surg       Date:  2006-08-15       Impact factor: 3.445

6.  Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection.

Authors:  H L Evans; D P Raymond; S J Pelletier; T D Crabtree; T L Pruett; R G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2001       Impact factor: 2.150

7.  Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis.

Authors:  A A Dahaba; B Hagara; A Fall; P H Rehak; W F List; H Metzler
Journal:  Br J Anaesth       Date:  2006-07-18       Impact factor: 9.166

8.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

9.  Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis.

Authors:  Peter Panhofer; Barbara Izay; Markus Riedl; Veronika Ferenc; Martin Ploder; Raimund Jakesz; Peter Götzinger
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

10.  ["Simplified Acute Physiology Score" (SAPS II) ina the assessment of severity of illness in surgical intensive care patients].

Authors:  A Agha; T Bein; D Fröhlich; S Höfler; D Krenz; K W Jauch
Journal:  Chirurg       Date:  2002-05       Impact factor: 0.955

View more
  10 in total

Review 1.  WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections.

Authors:  Massimo Sartelli; Federico Coccolini; Yoram Kluger; Ervis Agastra; Fikri M Abu-Zidan; Ashraf El Sayed Abbas; Luca Ansaloni; Abdulrashid Kayode Adesunkanmi; Boyko Atanasov; Goran Augustin; Miklosh Bala; Oussama Baraket; Suman Baral; Walter L Biffl; Marja A Boermeester; Marco Ceresoli; Elisabetta Cerutti; Osvaldo Chiara; Enrico Cicuttin; Massimo Chiarugi; Raul Coimbra; Elif Colak; Daniela Corsi; Francesco Cortese; Yunfeng Cui; Dimitris Damaskos; Nicola De' Angelis; Samir Delibegovic; Zaza Demetrashvili; Belinda De Simone; Stijn W de Jonge; Sameer Dhingra; Stefano Di Bella; Francesco Di Marzo; Salomone Di Saverio; Agron Dogjani; Therese M Duane; Mushira Abdulaziz Enani; Paola Fugazzola; Joseph M Galante; Mahir Gachabayov; Wagih Ghnnam; George Gkiokas; Carlos Augusto Gomes; Ewen A Griffiths; Timothy C Hardcastle; Andreas Hecker; Torsten Herzog; Syed Mohammad Umar Kabir; Aleksandar Karamarkovic; Vladimir Khokha; Peter K Kim; Jae Il Kim; Andrew W Kirkpatrick; Victor Kong; Renol M Koshy; Igor A Kryvoruchko; Kenji Inaba; Arda Isik; Katia Iskandar; Rao Ivatury; Francesco M Labricciosa; Yeong Yeh Lee; Ari Leppäniemi; Andrey Litvin; Davide Luppi; Gustavo M Machain; Ronald V Maier; Athanasios Marinis; Cristina Marmorale; Sanjay Marwah; Cristian Mesina; Ernest E Moore; Frederick A Moore; Ionut Negoi; Iyiade Olaoye; Carlos A Ordoñez; Mouaqit Ouadii; Andrew B Peitzman; Gennaro Perrone; Manos Pikoulis; Tadeja Pintar; Giuseppe Pipitone; Mauro Podda; Kemal Raşa; Julival Ribeiro; Gabriel Rodrigues; Ines Rubio-Perez; Ibrahima Sall; Norio Sato; Robert G Sawyer; Helmut Segovia Lohse; Gabriele Sganga; Vishal G Shelat; Ian Stephens; Michael Sugrue; Antonio Tarasconi; Joel Noutakdie Tochie; Matti Tolonen; Gia Tomadze; Jan Ulrych; Andras Vereczkei; Bruno Viaggi; Chiara Gurioli; Claudio Casella; Leonardo Pagani; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-09-25       Impact factor: 5.469

2.  One year experience of swine dermal non-crosslinked collagen prostheses for abdominal wall repairs in elective and emergency surgery.

Authors:  Giulia Montori; Federico Coccolini; Roberto Manfredi; Marco Ceresoli; Luca Campanati; Stefano Magnone; Michele Pisano; Elia Poiasina; Gabriela Nita; Fausto Catena; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2015-07-01       Impact factor: 5.469

3.  Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis.

Authors:  Marie Warrer Petersen; Anders Perner; Fredrik Sjövall; Morten Hylander Møller
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

4.  Negative Pressure Wound Therapy versus modified Barker Vacuum Pack as temporary abdominal closure technique for Open Abdomen management: a four-year experience.

Authors:  Giulia Montori; Niccolò Allievi; Federico Coccolini; Leonardo Solaini; Luca Campanati; Marco Ceresoli; Paola Fugazzola; Roberto Manfredi; Stefano Magnone; Matteo Tomasoni; Luca Ansaloni
Journal:  BMC Surg       Date:  2017-07-21       Impact factor: 2.102

Review 5.  Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference.

Authors:  Massimo Sartelli; Fausto Catena; Fikri M Abu-Zidan; Luca Ansaloni; Walter L Biffl; Marja A Boermeester; Marco Ceresoli; Osvaldo Chiara; Federico Coccolini; Jan J De Waele; Salomone Di Saverio; Christian Eckmann; Gustavo P Fraga; Maddalena Giannella; Massimo Girardis; Ewen A Griffiths; Jeffry Kashuk; Andrew W Kirkpatrick; Vladimir Khokha; Yoram Kluger; Francesco M Labricciosa; Ari Leppaniemi; Ronald V Maier; Addison K May; Mark Malangoni; Ignacio Martin-Loeches; John Mazuski; Philippe Montravers; Andrew Peitzman; Bruno M Pereira; Tarcisio Reis; Boris Sakakushev; Gabriele Sganga; Kjetil Soreide; Michael Sugrue; Jan Ulrych; Jean-Louis Vincent; Pierluigi Viale; Ernest E Moore
Journal:  World J Emerg Surg       Date:  2017-05-04       Impact factor: 5.469

6.  Global epidemiology of acute generalised peritonitis: a protocol for a systematic review and meta-analysis.

Authors:  Joel Noutakdie Tochie; Ndip Valirie Agbor; Tianyi Tianyi Frank Leonel; Aime Mbonda; Desmond Aji Abang; Celestin Danwang
Journal:  BMJ Open       Date:  2020-01-08       Impact factor: 2.692

7.  Primary Peritonitis Secondary to Streptococcus pyogenes in a Young Female Adult-A Case Report and Literature Review.

Authors:  Avelyn E Y Aw; James W K Lee; Kon Voi Tay
Journal:  Infect Dis Rep       Date:  2021-01-01

Review 8.  Tertiary peritonitis: A disease that should not be ignored.

Authors:  Hanna Santos Marques; Glauber Rocha Lima Araújo; Filipe Antônio França da Silva; Breno Bittencourt de Brito; Paulo Victor Dias Versiani; Jaqueline Silva Caires; Thiago de Carvalho Milet; Fabrício Freire de Melo
Journal:  World J Clin Cases       Date:  2021-04-06       Impact factor: 1.337

Review 9.  The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper.

Authors:  Massimo Sartelli; Fikri M Abu-Zidan; Luca Ansaloni; Miklosh Bala; Marcelo A Beltrán; Walter L Biffl; Fausto Catena; Osvaldo Chiara; Federico Coccolini; Raul Coimbra; Zaza Demetrashvili; Demetrios Demetriades; Jose J Diaz; Salomone Di Saverio; Gustavo P Fraga; Wagih Ghnnam; Ewen A Griffiths; Sanjay Gupta; Andreas Hecker; Aleksandar Karamarkovic; Victor Y Kong; Reinhold Kafka-Ritsch; Yoram Kluger; Rifat Latifi; Ari Leppaniemi; Jae Gil Lee; Michael McFarlane; Sanjay Marwah; Frederick A Moore; Carlos A Ordonez; Gerson Alves Pereira; Haralds Plaudis; Vishal G Shelat; Jan Ulrych; Sanoop K Zachariah; Martin D Zielinski; Maria Paula Garcia; Ernest E Moore
Journal:  World J Emerg Surg       Date:  2015-08-12       Impact factor: 5.469

Review 10.  Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).

Authors:  Massimo Sartelli; Dieter G Weber; Etienne Ruppé; Matteo Bassetti; Brian J Wright; Luca Ansaloni; Fausto Catena; Federico Coccolini; Fikri M Abu-Zidan; Raul Coimbra; Ernest E Moore; Frederick A Moore; Ronald V Maier; Jan J De Waele; Andrew W Kirkpatrick; Ewen A Griffiths; Christian Eckmann; Adrian J Brink; John E Mazuski; Addison K May; Rob G Sawyer; Dominik Mertz; Philippe Montravers; Anand Kumar; Jason A Roberts; Jean-Louis Vincent; Richard R Watkins; Warren Lowman; Brad Spellberg; Iain J Abbott; Abdulrashid Kayode Adesunkanmi; Sara Al-Dahir; Majdi N Al-Hasan; Ferdinando Agresta; Asma A Althani; Shamshul Ansari; Rashid Ansumana; Goran Augustin; Miklosh Bala; Zsolt J Balogh; Oussama Baraket; Aneel Bhangu; Marcelo A Beltrán; Michael Bernhard; Walter L Biffl; Marja A Boermeester; Stephen M Brecher; Jill R Cherry-Bukowiec; Otmar R Buyne; Miguel A Cainzos; Kelly A Cairns; Adrian Camacho-Ortiz; Sujith J Chandy; Asri Che Jusoh; Alain Chichom-Mefire; Caroline Colijn; Francesco Corcione; Yunfeng Cui; Daniel Curcio; Samir Delibegovic; Zaza Demetrashvili; Belinda De Simone; Sameer Dhingra; José J Diaz; Isidoro Di Carlo; Angel Dillip; Salomone Di Saverio; Michael P Doyle; Gereltuya Dorj; Agron Dogjani; Hervé Dupont; Soumitra R Eachempati; Mushira Abdulaziz Enani; Valery N Egiev; Mutasim M Elmangory; Paula Ferrada; Joseph R Fitchett; Gustavo P Fraga; Nathalie Guessennd; Helen Giamarellou; Wagih Ghnnam; George Gkiokas; Staphanie R Goldberg; Carlos Augusto Gomes; Harumi Gomi; Manuel Guzmán-Blanco; Mainul Haque; Sonja Hansen; Andreas Hecker; Wolfgang R Heizmann; Torsten Herzog; Adrien Montcho Hodonou; Suk-Kyung Hong; Reinhold Kafka-Ritsch; Lewis J Kaplan; Garima Kapoor; Aleksandar Karamarkovic; Martin G Kees; Jakub Kenig; Ronald Kiguba; Peter K Kim; Yoram Kluger; Vladimir Khokha; Kaoru Koike; Kenneth Y Y Kok; Victory Kong; Matthew C Knox; Kenji Inaba; Arda Isik; Katia Iskandar; Rao R Ivatury; Maurizio Labbate; Francesco M Labricciosa; Pierre-François Laterre; Rifat Latifi; Jae Gil Lee; Young Ran Lee; Marc Leone; Ari Leppaniemi; Yousheng Li; Stephen Y Liang; Tonny Loho; Marc Maegele; Sydney Malama; Hany E Marei; Ignacio Martin-Loeches; Sanjay Marwah; Amos Massele; Michael McFarlane; Renato Bessa Melo; Ionut Negoi; David P Nicolau; Carl Erik Nord; Richard Ofori-Asenso; AbdelKarim H Omari; Carlos A Ordonez; Mouaqit Ouadii; Gerson Alves Pereira Júnior; Diego Piazza; Guntars Pupelis; Timothy Miles Rawson; Miran Rems; Sandro Rizoli; Claudio Rocha; Boris Sakakushev; Miguel Sanchez-Garcia; Norio Sato; Helmut A Segovia Lohse; Gabriele Sganga; Boonying Siribumrungwong; Vishal G Shelat; Kjetil Soreide; Rodolfo Soto; Peep Talving; Jonathan V Tilsed; Jean-Francois Timsit; Gabriel Trueba; Ngo Tat Trung; Jan Ulrych; Harry van Goor; Andras Vereczkei; Ravinder S Vohra; Imtiaz Wani; Waldemar Uhl; Yonghong Xiao; Kuo-Ching Yuan; Sanoop K Zachariah; Jean-Ralph Zahar; Tanya L Zakrison; Antonio Corcione; Rita M Melotti; Claudio Viscoli; Perluigi Viale
Journal:  World J Emerg Surg       Date:  2016-07-15       Impact factor: 5.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.